Guo Q, Zhu X, Beeraka NM, Zhao R, Li S, Li F, Mahesh PA, Nikolenko VN, Fan R, Liu J. Projected epidemiological trends and burden of liver cancer by 2040 based on GBD, CI5plus, and WHO data. Sci Rep. 2024;14:28131. https://doi.org/10.1038/s41598-024-77658-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Fan N, He X, Zhu J, Zhang J, Lu L. Research progress in predicting hepatocellular carcinoma with portal vein tumour thrombus in the era of artificial intelligence. J Hepatocell Carcinoma. 2024;11:1429–38. https://doi.org/10.2147/JHC.S474922.

Article  PubMed  PubMed Central  Google Scholar 

Jipa AM, Makary MS. Locoregional Therapies for hepatobiliary tumors: contemporary strategies and novel applications. Cancers. 2024;16: 1271. https://doi.org/10.3390/cancers16071271.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Criss CR, Makary MS. Recent advances in image-guided locoregional therapies for primary liver tumors. Biology. 2023;12: 999. https://doi.org/10.3390/biology12070999.

Article  PubMed  PubMed Central  Google Scholar 

Hao K, Paik AJ, Han LH, Makary MS. Yttrium-90 radioembolization treatment strategies for management of hepatocellular carcinoma. World J Radiol. 2024;16:512–27. https://doi.org/10.4329/wjr.v16.i10.512.

Article  PubMed  PubMed Central  Google Scholar 

Liu P-H, Huo T-I, Miksad R. Hepatocellular carcinoma with portal vein tumor involvement: best management strategies. Semin Liver Dis. 2018;38:242–51. https://doi.org/10.1055/s-0038-1666805.

Article  CAS  PubMed  Google Scholar 

Zane KE, Makary MS. Locoregional therapies for hepatocellular carcinoma with portal vein tumor thrombosis. Cancers. 2021;13: 5430. https://doi.org/10.3390/cancers13215430.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nevarez N, Yopp A. Challenging the treatment paradigm: selecting patients for surgical management of hepatocellular carcinoma with portal vein tumor thrombus. J Hepatocell Carcinoma. 2021;8:851–60. https://doi.org/10.2147/JHC.S291530.

Article  PubMed  PubMed Central  Google Scholar 

Vikash S, Bteich F, Jiang J, Kanmaniraja D, Acuna-Villaorduna A, Saenger YM, Goel S, Kaubisch A. Malignant portal vein tumor thrombosis (PVTT) in patients with hepatocellular (HCC) carcinoma: Insights from a Western single-institutional cohort. J Clin Oncol. 2023;41:552–552. https://doi.org/10.1200/JCO.2023.41.4_suppl.552.

Article  Google Scholar 

Garcia-Tsao G. The Child-Turcotte classification: from gestalt to sophisticated statistics and back. Dig Dis Sci. 2016;61:3102–4. https://doi.org/10.1007/s10620-016-4319-7.

Article  PubMed  PubMed Central  Google Scholar 

Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329–38. https://doi.org/10.1055/s-2007-1007122.

Article  CAS  PubMed  Google Scholar 

Cheng S, Yang J, Shen F, Zhou W, Wang Y, Cong W, Yang GS, Cheng H, Hu H, Gao C, Guo J, Li A, Meng Y, Jiang X, Yang Y, Qian G, Luo M, Hu B, Man X, Zhang B, Su C, Zhou F, Li N, Shi J, Wang M, Zheng Y, Guo W, Sun J, Wang H, Lau W-Y, Wu M-C. Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement. Oncotarget. 2016;7:40816–40829. https://doi.org/10.18632/oncotarget.8386.

May BJ, Murthy R, Madoff DC. What’s new in transarterial therapies for hepatocellular carcinoma? Gastrointest Cancer Res GCR. 2012;5:S14–19.

PubMed  Google Scholar 

Wang G, Zhang J, Liu H, Zheng Q, Sun P. Embolization alone is as effective as TACE for unresectable HCC: systematic review and meta-analysis of randomized controlled trails. BMC Gastroenterol. 2024;24:195. https://doi.org/10.1186/s12876-024-03282-z.

Article  PubMed  PubMed Central  Google Scholar 

Sutphin PD, Lamus D, Kalva SP, Li J, Corbin IR. Interventional radiologic therapies for hepatocellular carcinoma: from where we began to where we are going. In: Hoshida Y, (ed). Hepatocellular Carcinoma. Cham: Springer International Publishing; 2019. p. 169–94.

Makary MS, Ramsell S, Miller E, Beal EW, Dowell JD. Hepatocellular carcinoma locoregional therapies: outcomes and future horizons. World J Gastroenterol. 2021;27:7462–79. https://doi.org/10.3748/wjg.v27.i43.7462.

Article  PubMed  PubMed Central  Google Scholar 

Quirk M, Kim YH, Saab S, Lee EW. Management of hepatocellular carcinoma with portal vein thrombosis. World J Gastroenterol. 2015;21:3462–71. https://doi.org/10.3748/wjg.v21.i12.3462.

Article  CAS  PubMed  PubMed Central  Google Scholar 

El Hassani Y, Janati Idrissi K, Haloua M, Alami B, Hafidi Y, Boubbou M, Maaroufi M, Alaoui Lamrani Moulay Y. Liver abscess and portal vein thrombosis complicating TACE for HCC: case study and literature review. J Clin Gastroenterol Treat. 2020;6. https://doi.org/10.23937/2469-584X/1510076.

Lo C-M, Ngan H, Tso W-K, Liu C-L, Lam C-M, Poon RT-P, Fan S-T, Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatol Baltim Md. 2002;35:1164–71. https://doi.org/10.1053/jhep.2002.33156.

Article  CAS  Google Scholar 

Cho Y, Choi JW, Kwon H, Kim KY, Lee BC, Chu HH, Lee DH, Lee HA, Kim GM, Oh JS, Hyun D, Lee IJ, Rhim H, Research Committee of the Korean Liver Cancer Association. Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association. Clin Mol Hepatol. 2023;29:521–41. https://doi.org/10.3350/cmh.2023.0202.

Article  Google Scholar 

Zhong B-Y, Jin Z-C, Chen J-J, Zhu H-D, Zhu X-L (2022) Role of transarterial chemoembolization in the treatment of hepatocellular carcinoma. J Clin Transl Hepatol. 000:000–000. https://doi.org/10.14218/JCTH.2022.00293.

Makary MS, Alexander J, Regalado LE, Jalil S, Mumtaz K. Clinical outcomes of DEB-TACE in locally advanced hepatocellular carcinoma: a 5-year real world experience. PLoS ONE. 2024;19: e0309693. https://doi.org/10.1371/journal.pone.0309693.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Lai L, Zhou C, Luo J, Wang H, Li M, Huang M. Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus. Cancer Imaging. 2023;23:70. https://doi.org/10.1186/s40644-023-00581-8.

Article  PubMed  PubMed Central  Google Scholar 

Peng Z, Fan W, Zhu B, Wang G, Sun J, Xiao C, Huang F, Tang R, Cheng Y, Huang Z, Liang Y, Fan H, Qiao L, Li F, Zhuang W, Peng B, Wang J, Li J, Kuang M. Lenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma: a phase III, randomized clinical trial (LAUNCH). J Clin Oncol. 2023;41:117–27. https://doi.org/10.1200/JCO.22.00392.

Article  CAS  PubMed  Google Scholar 

You R, Cheng Y, Diao L, Wang C, Leng B, Yu Z, Xu Q, Yin G. Immune-targeted therapy with or without transarterial chemoembolization (TACE) for advanced hepatocellular carcinoma with portal vein tumor thrombosis (PVTT): a multicenter retrospective study. Biomedicines. 2024;12: 2124. https://doi.org/10.3390/biomedicines12092124.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng Z, Fan W, Liu Z, Xiao H, Wu J, Tang R, Tu J, Qiao L, Huang F, Xie W, Zhuang W, Guo W, Li S, Hua Y, Shen S, He Q, Li D, Li J, Kuang M. Adjuvant transarterial chemoembolization with sorafenib for portal vein tumor thrombus: a randomized clinical trial. JAMA Surg. 2024;159:616–24. https://doi.org/10.1001/jamasurg.2024.0506.

Article  PubMed  PubMed Central  Google Scholar 

Dong A, Zhu M, Zhang Z, Fan W, Wu Z, Chen Y, Tu J, Zhang Y, Zhuang W, He X, Peng Z. Efficacy of radiation plus transarterial chemoembolization and lenvatinib in hepatocellular carcinoma with portal vein tumor thrombus. Front Oncol. 2023;13: 1320818. https://doi.org/10.3389/fonc.2023.1320818.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang M, Cheng J, Qian N. Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization plus lenvatinib for intermediate hepatocellular carcinoma. Sci Rep. 2024;14:25616. https://doi.org/10.1038/s41598-024-74801-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bannangkoon K, Hongsakul K, Tubtawee T. Impact of cone-beam computed tomography with automated feeder detection software on the survival outcome of patients with hepatocellular carcinoma during treatment with conventional transarterial chemoembolization. BMC Gastroenterol. 2021;21:419. https://doi.org/10.1186/s12876-021-02004-z.

Article  PubMed  PubMed Central  Google Scholar 

He C, Ge N, Wang X, Li H, Chen S, Yang Y. Conversion therapy of large unresectable hepatocellular carcinoma with ipsilateral portal vein tumor thrombus using portal vein embolization plus transcatheter arterial chemoembolization. Front Oncol. 2022;12: 923566. https://doi.org/10.3389/fonc.2022.923566.

Article  CAS